Category Archives: Transhuman News

Biotechnology And The Integrity Of Life: Taking Public Fears Seriously Ashgate Studies In Applied Et
ll4.me Biotechnology And The Integrity Of Life: Taking Public Fears Seriously Ashgate Studies In Applied Ethics - Michael Hauskeller Genetic engineering is still considered morally wrong by a large proportion of the public. Yet many scientists are puzzled about the public concern over a technology that, in their view, promises great benefits to humans and does not seem to cause more harm to animals than other practices which are rarely questioned. In this book, Michael Hauskeller takes public fears seriously and offers the idea of #39;biological integrity #39; as a clarifying principle which can then be analyzed to show that seemingly irrational public concerns about genetic engineering are not so irrational and that a philosophically sound justification of those concerns can indeed be given.Author: Hauskeller, Michael Publisher: Ashgate Gower Illustration: N Language: ENG Title: Biotechnology and the Integrity of Life: Taking Public Fears Seriously Ashgate Studies in Applied Ethics Pages: 00174 (Encrypted PDF) On Sale: 2007-12-01 SKU-13/ISBN: 9780754660446 Category: Social Science : General Category: History : General Genetic engineering is still considered morally wrong by a large proportion of the public. Yet many scientists are puzzled about the public concern over a technology that, in their view, promises grea michael hauskeller, history, generalFrom:lilliangoodin9854Views:0 0ratingsTime:00:13More inPeople Blogs

Read the rest here:
Biotechnology And The Integrity Of Life: Taking Public Fears Seriously Ashgate Studies In Applied Et - Video

Fighting For Human Rights
ll4.me Fighting For Human Rights In a world that is increasingly disillusioned with formal politics, this book identifies activism as a key means of realising human rights and as a new form of politics. People are no longer prepared to wait for governments and international institutions for act on human rights concerns. "Fighting for Human Rights" documents and compares successful high profile campaigns to cancel debt, ban landmines, and set up the International Criminal Court as well as emerging campaigns that focus on HIV/Aids, genetic engineering, environmental justice, democratization, and blood diamonds. Motivated diverse international movements, these campaigns aim to establish international agreements that will become the basis for processes of monitoring and enforcement. Publisher: Routledge Illustration: N Language: ENG Title: Fighting for Human Rights Pages: 00000 (Encrypted PDF) On Sale: 2004-07-14 SKU-13/ISBN: 9780415312929 Category: Political Science : Political Freedom Security - Civil Rig Category: Political Science : International Relations - General Category: Social Science : General In a world that is increasingly disillusioned with formal politics, this book identifies activism as a key means of realising human rights and as a new form of politics. People are no longer prepared social science, generalFrom:barrynielsen9854Views:0 0ratingsTime:00:13More inPeople Blogs

Read the original here:
Fighting For Human Rights - Video

Lipid Biotechnology
ll4.me Lipid Biotechnology Discussing a variety of lipid-active enzymes from animal, plant, fungal, and microbial sources, Lipid Biotechnology covers modern techniques in genetic engineering. This text presents the latest advances in supercritical fluid technology, biocatalysis, bioprocess engineering, and crop breeding. Lipid Biotechnology offers a thorough review of the most recent principles and approaches used in the development and design of lipids for cosmetic, industrial and pharmaceutical, and food products. The authors provide in-depth analyses of the structure, metabolic and enzymatic functions and mechanisms, defensive and catalytic properties, industrial uses, and other applications of oxilipins, lipases, and other fatty acids. Related discussions include reaction conditions, reactor design, immobilization technology, and large-scale manufacturing. Publisher: Marcel Dekker Illustration: N Language: ENG Title: Lipid Biotechnology Pages: 00000 (Encrypted PDF) On Sale: 2002-01-22 SKU-13/ISBN: 9780824744182 Category: Technology Engineering : General Discussing a variety of lipid-active enzymes from animal, plant, fungal, and microbial sources, Lipid Biotechnology covers modern techniques in genetic engineering. This text presents the latest advan technology, engineering, generalFrom:aidataylor326Views:0 0ratingsTime:00:10More inPeople Blogs

Read more from the original source:
Lipid Biotechnology - Video

Public release date: 13-Nov-2012 [ | E-mail | Share ]

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 x2156 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, November 12, 2012--Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial tumor site. Effective therapy for metastatic cancer requires a combination of treatments, and the benefits of adding radionuclide therapy are explored in three studies published in Journal of Clinical Investigation, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Journal of Clinical Investigation website.

"The preliminary therapeutic results reported in these case studies using radionuclide multimodality approaches are encouraging," says Co-Editor-in-Chief Donald J. Buchsbaum, PhD, Division of Radiation Biology, Department of Radiation Oncology, University of Alabama at Birmingham. "The outcomes described in these small, single center studies must be confirmed in larger trials before they can be translated into widespread oncology practice."

J. Harvey Turner, MD, FRACP, The University of Western Australia, Fremantle, coauthored two of the case studies and, in the Perspective article "Multimodality Radionuclide Therapy of Progressive Disseminated Lymphoma and Neuroendocrine Tumors as a Paradigm for Cancer Control," he states that the synergistic effects that can be achieved by combining chemotherapy and radionuclides "has the potential to enhance efficacy and minimize toxicity." Although advanced forms of lymphoma and neuroendocrine tumors are usually incurable, multimodal treatment approaches may be able to stop or slow tumor progression, achieve durable remission, prolong patient survival, and improve their quality of life.

###

Paul Kruger, Julian Cooney, and J. Harvey Turner report that more patients survived longer and were free of disease when a radioimmunotherapeutic agent was added to their treatment regimen in the article "Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma."

Phillip Claringbold, Richard Price, and J. Harvey Turner added a lutetium-177 labeled peptide to the therapeutic regimen of a group of patients with advanced neuroendocrine cancer and described substantially improved tumor control rates with no significant side effects. They report their findings in "Phase I-II Study of Radiopeptide 177Lu-Octreotate in Combination with Capecitabine and Temozolomide in Advanced Low-Grade Neuroendocrine Tumors."

About the Journal

Journal of Clinical Investigation, published 10 times a year in print and online, is under the editorial leadership of Editors Donald J. Buchsbaum, PhD, Division of Radiation Biology, Department of Radiation Oncology, University of Alabama at Birmingham, and Robert K. Oldham, MD, Lower Keys Cancer Center, Key West, FL. Journal of Clinical Investigation is the only journal with a specific focus on cancer biotherapy, including monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapy. The Journal includes extensive reporting on advancements in radioimmunotherapy and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments. Topics include antibody drug conjugates, fusion toxins and immunotoxins, nanoparticle therapy, vascular therapy, and inhibitors of proliferation signaling pathways.

Read the rest here:
Can the addition of radiolabeled treatments improve outcomes in advanced metastatic disease?

Applications Of Plant Cell And Tissue Culture - Ciba Foundation Symposium
ll4.me Applications Of Plant Cell And Tissue Culture - Ciba Foundation Symposium This work deals with basic plant physiology and cytology, and addresses the practical exploitation of plants, both as crops and as sources of useful compounds produced as secondary metabolites. Covers problems of commercial exploitation, socio-legal aspects of genetic engineering of crop plants, and of the difficulties of marketing natural compunds produced by cells under artificial conditions.Author: CIBA Foundation Symposium Publisher: Wiley Illustration: N Language: ENG Title: Applications of Plant Cell and Tissue Culture Pages: 00280 (Encrypted PDF) On Sale: 2008-04-30 SKU-13/ISBN: 9780471918868 Category: Science : Life Sciences - Botany This work deals with basic plant physiology and cytology, and addresses the practical exploitation of plants, both as crops and as sources of useful compounds produced as secondary metabolites. Covers ciba foundation symposium, science, life sciences, botanyFrom:barrynielsen9854Views:0 0ratingsTime:00:10More inPeople Blogs

View original post here:
Applications Of Plant Cell And Tissue Culture - Ciba Foundation Symposium - Video

Public release date: 13-Nov-2012 [ | E-mail | Share ]

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, November 13, 2012The average incidence of traumatic brain injury (TBI) among service members deployed in Middle East conflict zones has increased 117% in recent years, mainly due to proximity to explosive blasts. Therapeutic exposure to a high oxygen environment was hoped to minimize the concussion symptoms resulting from mild TBI, but hyperbaric oxygen (HBO2) treatment may not offer significant advantages, according to an article in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Neurotrauma website at http://www.liebertpub.com/neu.

A prospective trial conducted at the U.S. Air Force School of Aerospace Medicine evaluated the benefits of HBO2 therapy on post-concussion symptoms in 50 military servicepersons who had suffered at least one combat-related mild TBI. The study, "The Effect of Hyperbaric Oxygen on Symptoms Following Mild Traumatic Brain Injury," compared the results following 30 sessions of either HBO2 (2.4 atmospheres absolute pressure) or sham treatment over an 8-week period.

George Wolf, MD and Leonardo Profenna, MD, U.S. Air Force School of Aerospace Medicine (San Antonio, TX), David Cifu, MD and William Carne, PhD, Virginia Commonwealth University (Richmond), and Laura Baugh, MD, Uniformed Services University of the Health Sciences Department of Neurology (Bethesda, MD), present data demonstrating that both patient groups showed significant improvement in concussion assessment and cognitive testing scores over the course of the study.

"This is a particularly important communication that addresses a continued area of controversy, particularly as it relates to the treatment of our military personnel sustaining mild traumatic brain injury," says John T. Povlishock, PhD, Editor-in-Chief of Journal of Neurotrauma and Professor, VCU Neuroscience Center, Medical College of Virginia, Richmond. "While the authors stress that based upon their findings, larger multi-center, randomized, controlled, double-blinded clinical trials should be conducted, the compelling data in this communication does not support any therapeutic value for hyperbaric oxygen treatment, striking a cautionary note for those involved in the care and management of this patient population."

###

About the Journal

Journal of Neurotrauma is an authoritative peer-reviewed journal published 24 times per year in print and online that focuses on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury. Emphasis is on the basic pathobiology of injury to the nervous system, and papers and reviews evaluate preclinical and clinical trials targeted at improving the early management and long-term care and recovery of patients with traumatic brain injury. Journal of Neurotrauma is the Official Journal of the National Neurotrauma Society and the International Neurotrauma Society. Complete tables of content and a sample issue may be viewed on the Journal of Neurotrauma website at http://www.liebertpub.com/neu.

About the Publisher

Read more:
Should hyperbaric oxygen therapy be used to treat combat-related mild traumatic brain injury?